CymaBay Therapeutics
Stock Forecast, Prediction & Price Target
CymaBay Therapeutics Financial Estimates
CymaBay Therapeutics Revenue Estimates
CymaBay Therapeutics EBITDA Estimates
CymaBay Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $31.07M 0% | Avg: $145.14M Low: $145.14M High: $145.14M avg. 367.09% | Avg: $321.05M Low: $321.05M High: $321.05M avg. 121.20% | Avg: $537.91M Low: $537.91M High: $537.91M avg. 67.54% | Avg: $793.78M Low: $793.78M High: $793.78M avg. 47.56% |
Net Income
% change YoY
| $-89.99M N/A | $-106.00M -17.78% | $-105.37M 0.59% | Avg: $-77.88M Low: $-77.88M High: $-77.88M avg. 26.08% | Avg: $41.41M Low: $41.41M High: $41.41M avg. 153.18% | Avg: $191.87M Low: $191.87M High: $191.87M avg. 363.24% | Avg: $333.12M Low: $333.12M High: $333.12M avg. 73.61% |
EBITDA
% change YoY
| $-86.89M N/A | $-92.40M -6.33% | $-100.99M -9.30% | Avg: $87.08M Low: $87.08M High: $87.08M avg. 186.22% | Avg: $192.63M Low: $192.63M High: $192.63M avg. 121.20% | Avg: $322.75M Low: $322.75M High: $322.75M avg. 67.54% | Avg: $476.27M Low: $476.27M High: $476.27M avg. 47.56% |
EPS
% change YoY
| -$1.27 N/A | -$1.21 4.72% | -$0.99 18.18% | Avg: -$0.73 Low: -$0.73 High: -$0.73 avg. 25.92% | Avg: $0.39 Low: $0.39 High: $0.39 avg. 153.18% | Avg: $1.81 Low: $1.81 High: $1.81 avg. 363.24% | Avg: $3.14 Low: $3.14 High: $3.14 avg. 73.61% |
Operating Expenses
% change YoY
| $86.89M N/A | $92.40M 6.33% | $132.07M 42.93% | Avg: $164.64M Low: $164.64M High: $164.64M avg. 24.66% | Avg: $364.20M Low: $364.20M High: $364.20M avg. 121.20% | Avg: $610.20M Low: $610.20M High: $610.20M avg. 67.54% | Avg: $900.46M Low: $900.46M High: $900.46M avg. 47.56% |
FAQ
What is CymaBay Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 154.03% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -77.88M, average is -77.88M and high is -77.88M.
What is CymaBay Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 150.85% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $145.14M, average is $145.14M and high is $145.14M.
What is CymaBay Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 153.99% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.73, average is -$0.73 and high is $-0.73.